(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | -113.25%-5.53B | -31.93%13.86B | 235.40%50.47B | 131.74%62.72B | -292.06%-14.41B | 345.77%41.71B | 180.22%20.36B | 412.10%15.05B | 183.08%27.06B | 2,745.53%7.5B |
Other non cash items | -70.36%6.82B | -72.72%4.11B | -74.94%2.75B | 42.60%32.35B | -233.46%-16.69B | 312.10%23.01B | 398.05%15.08B | 598.00%10.96B | 239.51%22.69B | 428.24%12.51B |
Change In working capital | 74.72%-7.32B | -321.44%-55.64B | 66.67%-4.67B | 67.18%-3.79B | 1,750.09%14.03B | -527.75%-28.93B | 480.80%25.13B | -1,190.40%-14.01B | -196.18%-11.53B | -78.52%758.25M |
-Change in receivables | -405.20%-33.04B | -47.60%-7.65B | 519.21%16.06B | -1.72%-8.82B | -6.46%6.73B | 36.43%-6.54B | -83.74%-5.18B | -38.80%-3.83B | -1,372.81%-8.67B | 47.21%7.2B |
-Change in inventory | 393.97%44.52B | -19.29%14.66B | -382.04%-31.54B | 193.74%13.86B | -67.39%-24.5B | 4.68%9.01B | 308.14%18.16B | 37,388.64%11.18B | -302.02%-14.78B | -1,634.02%-14.64B |
-Change in other current assets | 447.04%1.29B | -93.17%118M | 359.90%5.19B | -425.64%-1.76B | -163.71%-1.12B | 60.76%-372M | 1,119.09%1.73B | -388.07%-2B | --539.51M | --1.75B |
-Change in other current liabilities | -8.02%-256M | 19.19%12.16B | -20.50%-12.89B | -162.11%-7.07B | -154.63%-6.33B | -330.78%-237M | 827.51%10.2B | -747.48%-10.7B | 4,079.20%11.38B | 12,108.55%11.59B |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -128.16%-8.9B | -183.97%-51.13B | 107.18%24.98B | 158.45%114.85B | -56.64%10.32B | 168.88%31.59B | 1,137.51%60.89B | 204.36%12.06B | 261.08%44.44B | 290.68%23.81B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Net PPE purchase and sale | -125.78%-10.05B | -90.40%-7.77B | -117.56%-4.2B | -84.57%-9.99B | 327.23%475.19M | -6.25%-4.45B | -632.65%-4.08B | -322.27%-1.93B | -342.07%-5.41B | 71.11%-209.13M |
Net investment purchase and sale | 500.86%34.01B | 679.84%40.3B | 338.45%6.11B | -455.72%-158.18B | -843.28%-152.3B | 24.31%-8.48B | 1,120.43%5.17B | -324.56%-2.56B | -577.88%-28.46B | ---16.15B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 305.71%24.09B | 1,373.59%33.54B | 142.47%1.91B | -309.20%-42.9B | -702.71%-28.97B | -146.50%-11.71B | 313.99%2.28B | -323.57%-4.49B | -317.80%-10.48B | -543.48%-3.61B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | -207.33%-7.89B | 795.26%21.28B | -323.45%-13.72B | -95.73%-15.64B | -189.17%-26.07B | 750.20%7.35B | -273.85%-3.06B | 483.36%6.14B | -20.16%-7.99B | -165.16%-9.02B |
Cash dividends paid | ---- | ---- | ---- | -368.73%-24.25B | 1,469.66%24.64B | -506.71%-5.29B | ---- | ---- | -52.89%-5.17B | -193.88%-1.8B |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 9.30%-13.63B | 128.73%16.73B | -370.47%-24.38B | -96.36%-67.19B | 150.50%11.23B | -185.65%-15.03B | -1,476.39%-58.22B | -71.03%-5.18B | -103.71%-34.22B | -242.56%-22.24B |
Net cash flow | ||||||||||
Beginning cash position | -51.79%3.42B | 59.32%4.75B | 268.00%3.39B | -74.92%607.91M | 257.56%9.43B | 672.70%7.09B | 329.16%2.98B | -2.69%922M | 217.39%2.42B | 681.91%2.64B |
Current changes in cash | -98.28%38M | -149.75%-1.96B | -34.22%1.35B | 189.75%1.63B | -128.93%-6.57B | 68.45%2.21B | 182,414.81%3.94B | 911.98%2.06B | -12,484.84%-1.82B | -974.26%-2.87B |
End cash Position | -58.18%3.94B | -51.79%3.42B | 59.32%4.75B | 268.10%2.24B | 268.10%2.24B | 257.56%9.43B | 672.70%7.09B | 329.16%2.98B | -21.90%607.91M | -21.90%607.91M |
Free cash flow | -169.58%-18.94B | -203.71%-58.9B | 106.58%20.77B | 168.70%104.87B | -54.24%10.8B | 260.03%27.22B | 1,200.66%56.79B | 187.32%10.06B | 252.13%39.03B | 339.45%23.6B |
Currency Unit | ARS | ARS | ARS | ARS | ARS | ARS | ARS | ARS | ARS | ARS |
No Data